Share Options (Tables)

6 Months Ended

Jun. 30, 2023

Share-Based Payment Arrangement [Abstract]

Schedule of outstanding share options separated ranges of exercise prices

The following table presents the Company’s share option activity for employees and members of the Board of Directors of the Company under the Plan for the periods of six months ended June 30, 2023 and 2022:

	Number of Share Options			Weighted Average Exercise Price		Weighted average remaining contractual life		Intrinsic value
				$		(years)		$
Outstanding as of December 31, 2022		1,570,991			1.78		4.97		2,435
Granted		88,800			3.67		9.70		-
Exercised		(18,448	)		-		-		-
Forfeited or expired		(72,357	)		1.96		-		-
Outstanding as of June 30, 2023 (unaudited)		1,568,986			1.88		4.85		1,475
Exercisable as of June 30, 2023 (unaudited)		1,096,887			1.75		3.09		1,174

	Number of Share Options			Weighted Average Exercise Price		Weighted average remaining contractual life		Intrinsic value
				$		(years)		$
Outstanding as of December 31, 2021		1,367,168			1.75		5.72		9,365
Forfeited or expired		(15,360	)		-		-		-
Outstanding as of June 30, 2022 (unaudited)		1,351,808			1.75		5.29		9,260
Exercisable as of June 30, 2022 (unaudited)		1,000,864			1.65		4.18		6,956

Schedule of outstanding share options separated ranges of exercise prices

The outstanding share options as of June 30, 2023 have been separated into ranges of exercise prices, as follows:

Exercise price	Share options outstanding as of June 30, 2023		Weighted average remaining contractual term		Share options exercisable as of June 30, 2023		Weighted average remaining contractual term
	Unaudited
			(years)				(years)
-		152,640		0.54		152,640		0.54
1.14		219,840		0.91		219,840		0.91
1.67		43,200		1.71		43,200		1.71
1.74		12,800		9.81		-		-
1.83		907,579		6.41		532,008		4.71
3.20		28,127		7.30		14,063		6.44
3.79		60,000		1.09		60,000		1.09
4.00		76,000		9.68		6,336		9.68
4.17		28,800		2.54		28,800		2.54
5.12		40,000		6.04		40,000		6.04
		1,568,986				1,096,887

Schedule of assumptions used to estimate the fair values of the share options granted

The following table presents the assumptions used to estimate the fair values of the share options granted in the reported periods presented:

	Six-month period ended June 30,
	2023			2022
Volatility (%)		61.4	%		-
Risk-free interest rate (%)		3.7%-4.3%			-
Dividend yield (%)		-			-
Expected life (years)		6.25			-
Exercise price ($)		1.74-4.00			-
Share price ($)		1.74-3.73			-

Schedule of total compensation cost related to all of the company’s equity-based awards recognized

The total compensation cost related to all of the Company’s equity-based awards recognized during the periods of six months ended June 30, 2023 and 2022 was comprised as follows:

	Six-month period ended June 30,
	2023		2022
	Unaudited
Research and development	$	122	$	71
Sales and marketing		14		27
General and administrative		40		14
	$	176	$	112